Cortexyme shares owned by UBS Group
Historical chart of UBS Group investment in Cortexyme
Tip: Access up to 7 years of quarterly data
All positions including Cortexyme held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cortexyme by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $536 | 505 | 1.06 |
| 2023-12-31 | $530 | 505 | 1.05 |
| 2023-09-30 | $7.5k | 6.7k | 1.12 |
| 2023-06-30 | $1.4k | 912 | 1.50 |
| 2023-03-31 | $507 | 325 | 1.56 |
| 2022-12-31 | $29k | 46k | 0.64 |
| 2022-09-30 | $0 | 33k | 0.00 |
| 2022-06-30 | $56k | 25k | 2.22 |
| 2022-03-31 | $158k | 26k | 6.15 |
| 2021-12-31 | $0 | 16k | 0.00 |
| 2021-09-30 | $5.4M | 67k | 80.00 |
| 2021-06-30 | $537k | 10k | 52.94 |
| 2021-03-31 | $1.3M | 36k | 36.02 |
| 2020-12-31 | $292k | 11k | 27.69 |
| 2020-09-30 | $1.0M | 20k | 50.02 |
| 2020-06-30 | $1.1M | 23k | 46.38 |
| 2020-03-31 | $1.2M | 26k | 45.62 |
| 2019-12-31 | $1.5M | 27k | 56.00 |
| 2019-09-30 | $418k | 17k | 24.95 |
| 2019-06-30 | $290k | 6.8k | 42.55 |